Clinical Trial: Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Pharmacokinetic Study of Nilotinib in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Showing Failure to Both Imatinib and Sunitinib
Brief Summary: In patients who are receiving nilotinib, nilotinib plasma levels will be measured after 1 month of nilotinib treatment. The relationship between surgery type and nilotinib pharmakokinetic properties will be investigated in this study.
Detailed Summary:
Sponsor: Asan Medical Center
Current Primary Outcome: nilotinib pharmacokinetics [ Time Frame: Up to 3years ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Asan Medical Center
Dates:
Date Received: September 11, 2009
Date Started: January 2009
Date Completion:
Last Updated: July 3, 2013
Last Verified: July 2013